100 related articles for article (PubMed ID: 24527758)
1. Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Özhan G; Mutur M; Ercan G; Alpertunga B
Genet Test Mol Biomarkers; 2014 Apr; 18(4):223-8. PubMed ID: 24527758
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer.
Kiyohara C
J Epidemiol; 2000 Sep; 10(5):349-60. PubMed ID: 11059519
[TBL] [Abstract][Full Text] [Related]
3. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
4. Associations between the functional polymorphisms in the ABCB1 transporter gene and colorectal cancer risk: a case-control study in Turkish population.
Özhan G; Kara M; Sari FM; Yanar HT; Ercan G; Alpertunga B
Toxicol Mech Methods; 2013 May; 23(4):235-9. PubMed ID: 23193993
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
6. Influence of the functional polymorphisms in the organic anion transporting polypeptide 1B1 in the susceptibility to colorectal cancer.
Ozhan G; Kara M; Sari FM; Yanar HT; Alpertunga B
Genet Test Mol Biomarkers; 2013 Mar; 17(3):214-8. PubMed ID: 23216274
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Landi S; Gemignani F; Moreno V; Gioia-Patricola L; Chabrier A; Guino E; Navarro M; de Oca J; Capellà G; Canzian F;
Pharmacogenet Genomics; 2005 Aug; 15(8):535-46. PubMed ID: 16006997
[TBL] [Abstract][Full Text] [Related]
8. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
9. [A case-control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer].
Chen K; Jin MJ; Fan CH; Song L; Jiang QT; Yu WP; Ma XY; Yao KY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):659-64. PubMed ID: 16471212
[TBL] [Abstract][Full Text] [Related]
10. Associations between CYP1A1 rs1048943 A > G and rs4646903 T > C genetic variations and colorectal cancer risk: Proof from 26 case-control studies.
Zhu X; Wang Z; He J; Wang W; Xue W; Wang Y; Zheng L; Zhu ML
Oncotarget; 2016 Aug; 7(32):51365-51374. PubMed ID: 27384991
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk.
Bethke L; Webb E; Sellick G; Rudd M; Penegar S; Withey L; Qureshi M; Houlston R
BMC Cancer; 2007 Jul; 7():123. PubMed ID: 17615053
[TBL] [Abstract][Full Text] [Related]
12. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma.
Tamer L; Ercan B; Ercan S; Ateş N; Ateş C; Ocal K; Dirlik M; Aydin S; Atik U
Int J Gastrointest Cancer; 2006; 37(1):1-5. PubMed ID: 17290075
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of xenobiotic-metabolizing genes and colorectal cancer risk in patients with lynch syndrome: A retrospective cohort study in Taiwan.
Kamiza AB; You JF; Wang WC; Tang R; Chang CY; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
Environ Mol Mutagen; 2018 Jan; 59(1):69-78. PubMed ID: 28714190
[TBL] [Abstract][Full Text] [Related]
15. Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary.
Kiss I; Orsós Z; Gombos K; Bogner B; Csejtei A; Tibold A; Varga Z; Pázsit E; Magda I; Zölyomi A; Ember I
Anticancer Res; 2007; 27(4C):2931-7. PubMed ID: 17695473
[TBL] [Abstract][Full Text] [Related]
16. The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population.
Arici M; Özhan G
Saudi Pharm J; 2017 Feb; 25(2):294-297. PubMed ID: 28344482
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Bozina N; Bradamante V; Lovrić M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):217-42. PubMed ID: 19581216
[TBL] [Abstract][Full Text] [Related]
18. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis.
Pande M; Amos CI; Eng C; Frazier ML
Mol Carcinog; 2010 Nov; 49(11):974-80. PubMed ID: 20886582
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
20. CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.
Arici M; Özhan G
Saudi Pharm J; 2017 Mar; 25(3):376-380. PubMed ID: 28344492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
